Utilization of hepatitis C virus RNA–positive donor liver for transplant to hepatitis C virus RNA–negative recipient

Behnam Saberi; James P. Hamilton; Christine M. Durand; Zhiping Li; Benjamin Philosophe; Andrew M. Cameron; Mark S. Sulkowski; Ahmet Gurakar

doi:10.1002/lt.24838

Utilization of hepatitis C virus RNA–positive donor liver for transplant to hepatitis C virus RNA–negative recipient

Behnam Saberi, James P. Hamilton, Christine M. Durand, Zhiping Li, Benjamin Philosophe, Andrew M. Cameron, Mark S. Sulkowski, Ahmet Gurakar

School of Medicine

Research output: Contribution to journal › Letter › peer-review

23 Scopus citations

Original language	English (US)
Pages (from-to)	140-143
Number of pages	4
Journal	Liver Transplantation
Volume	24
Issue number	1
DOIs	https://doi.org/10.1002/lt.24838
State	Published - Jan 2018

ASJC Scopus subject areas

Surgery
Hepatology
Transplantation

Access to Document

10.1002/lt.24838

Cite this

@article{02e1845a9cd5436c824d57c6c9be7ec6,

title = "Utilization of hepatitis C virus RNA–positive donor liver for transplant to hepatitis C virus RNA–negative recipient",

author = "Behnam Saberi and Hamilton, {James P.} and Durand, {Christine M.} and Zhiping Li and Benjamin Philosophe and Cameron, {Andrew M.} and Sulkowski, {Mark S.} and Ahmet Gurakar",

note = "Funding Information: Christine M. Durand received research grants and served on advisory boards for Gilead, Merck, and BMS. Mark S. Sulkowski received research grants and personal fees from AbbVie, personal fees from Cocrystal, research grants and personal fees from Gilead, research grants and personal fees from Janssen, research grants and personal fees from Merck, and personal fees from Trek. Ahmet Gurakar served on the advisory board for Gilead and BMS. Zhiping Li advises for Gilead.",

year = "2018",

month = jan,

doi = "10.1002/lt.24838",

language = "English (US)",

volume = "24",

pages = "140--143",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Utilization of hepatitis C virus RNA–positive donor liver for transplant to hepatitis C virus RNA–negative recipient

AU - Saberi, Behnam

AU - Hamilton, James P.

AU - Durand, Christine M.

AU - Li, Zhiping

AU - Philosophe, Benjamin

AU - Cameron, Andrew M.

AU - Sulkowski, Mark S.

AU - Gurakar, Ahmet

N1 - Funding Information: Christine M. Durand received research grants and served on advisory boards for Gilead, Merck, and BMS. Mark S. Sulkowski received research grants and personal fees from AbbVie, personal fees from Cocrystal, research grants and personal fees from Gilead, research grants and personal fees from Janssen, research grants and personal fees from Merck, and personal fees from Trek. Ahmet Gurakar served on the advisory board for Gilead and BMS. Zhiping Li advises for Gilead.

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85038564251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038564251&partnerID=8YFLogxK

U2 - 10.1002/lt.24838

DO - 10.1002/lt.24838

M3 - Letter

C2 - 28779557

AN - SCOPUS:85038564251

SN - 1527-6465

VL - 24

SP - 140

EP - 143

JO - Liver Transplantation

JF - Liver Transplantation

IS - 1

ER -

Utilization of hepatitis C virus RNA–positive donor liver for transplant to hepatitis C virus RNA–negative recipient

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this